MyoStrain CMR Testing of Ischemia With Low Levels of Stress



Status:Completed
Conditions:Angina, Peripheral Vascular Disease, Peripheral Vascular Disease, Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:18 - 80
Updated:12/20/2018
Start Date:November 8, 2017
End Date:October 18, 2018

Use our guide to learn which trials are right for you!

This prospective, observational study evaluates the accuracy of stress testing with the
MyoStrain SENC CMR Imaging System to detect myocardial ischemia and viability in patients
with suspected coronary artery disease using low levels of stress.

This prospective, single center study evaluates the MyoStrain SENC CMR Imaging System for the
detection of myocardial ischemia and viability during conventional Cardiac Magnetic Resonance
(CMR) wall motion stress testing. Patients with known or suspected coronary artery disease
and scheduled for cardiac catheterization will be consented for inclusion in the study and
evaluated during stress testing with low dose Dobutamine as the stressor agent. Data obtained
with the MyoStrain SENC CMR Imaging System will be for observational purposes and will not be
used to alter patient management.

Inclusion Criteria:

- Known or suspected Coronary Artery Disease

- Symptoms potentially due to CAD; stable angina

- Positive imaging stress test or negative stress test but typical angina or anginal
equivalent

- Negative Troponin with unstable angina

- Invasive coronary angiography planned within 3 months of CMR

- Provided written consent

Exclusion Criteria:

- Pregnancy

- Contraindication to Magnetic Resonance Imaging

- Prior allergy to Dobutamine

- Severe aortic stenosis

- Hypertrophic Cardiomyopathy

- Clinically significant Ventricular Tachycardia that would prohibit Dobutamine
administration
We found this trial at
1
site
Raleigh, North Carolina 27610
Phone: 919-231-6132
?
mi
from
Raleigh, NC
Click here to add this to my saved trials